CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies

Faculty Science Year: 2024
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Scientific Reports Springer Nature Volume:
Keywords : , nanoparticles , green synthesis , significant anti-Helicobacter pylori    
Abstract:
Helicobacter pylori (H. pylori) is a universal health intimidation as mentioned by the World Health Organization. The primary causal agent linked to a number of illnesses, including inflammation and the development of stomach ulcers, is Helicobacter pylori. Since, H. pylori develops antibiotic resistance quickly, current H. pylori treatment approaches are becoming less effective. Our research aims to highlight novel formulation antibiotics using CuO-NPs as catalysts and studied their activity as anti-helicobacter pylori supported by computational studies (POM analysis and molecular docking) software. They were designed for anti-Helicobacter Pylori action. All compounds revealed a bactericidal effect better than the reference McFarland standards.
    
     
 
       

Author Related Publications

    Department Related Publications

    • Hamdy Aldedamony , "Studies on Portland Blast-Furnace Slag Cement with Limestone as a Retarder”", Indian J. Eng. & Sci, 1995 More
    • Hamdy Aldedamony , "Resistivity of an Artificial Pozzolanic Cement to Chloride Solutions”", Silic. Ind.,, 1994 More
    • Ragaa Sheikh Shuhaib, "Utility of Oxidation-Reduction Reaction for Determination of Gemifloxacin Mesylate and Moxifloxacin HCl in Pure Form and in Pharmaceutical Formulations using N-Bromosuccinimide", OMICS Publishing Group, 2013 More
    • Ayman AboulFotouh Gouda Sallem, "Spectophotometricmethods for determination of cefdinir in pharmaceutical formulations via derivatization with 1,2-naphthoquinone-4-sulfonate and 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole", Wiley Online Library, 2011 More
    • Ragaa Sheikh Shuhaib, "Kinetic Spectrophotometric Determination of Gemifloxacin Mesylate and Moxifloxacin Hydrochloride in Pharmaceutical Preparations Using 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole", Hindawi Publishing Corporation, 2014 More
    Tweet